Reference
US Food & Drug Administration (FDA). AuroMedics Pharma LLC Issues Voluntary Nationwide Recall of Polymyxin B for Injection USP, 500,000 Unit per Vial, Due to the Presence of Particulate Matter. Internet Document : 3 Feb 2022. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/auromedics-pharma-llc-issues-voluntary-nationwide-recall-polymyxin-b-injection-usp-500000-unit-vial
Rights and permissions
About this article
Cite this article
Voluntary recall of AuroMedics' polymyxin-B injection due to contamination. Reactions Weekly 1893, 6 (2022). https://doi.org/10.1007/s40278-022-09789-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-09789-7